Lilly’s Mounjaro Helps Patients Lose More Weight Than Novo’s Ozempic: Study

Eli Lilly’s Mounjaro (tirzepatide) is able to elicit greater weight loss in overweight or obese patients than Novo Nordisk’s Ozempic (semaglutide), according to the results of a new observational study.